
Sign up to save your podcasts
Or
Introducing S5:E2 Drug Affordability: The High Cost of Healing from Unseen Upside: Investments Beyond Their Returns.
Follow the show: Unseen Upside: Investments Beyond Their Returns
Prescription drug prices in the United States are 2.78 times higher than in other developed countries, but why?
We untangle the barriers surrounding drug affordability and find out why accessing life-saving medications is costly to so many. Joined by experts, advocates, and one Cystic Fibrosis patient relying on expensive medication to live, we examine the complex factors contributing to the high costs of drugs, from research and development to pricing strategies and supply chain dynamics. We also investigate potential solutions to improve access and affordability without compromising on drug innovation.
Guests include:
Unseen Upside: Investments Beyond Their Returns is developed in partnership with PRX, an award-winning podcast media company.
Cambridge Associates is a global investment firm that works with endowments, foundations, healthcare systems, pension plans, and private clients to implement and manage custom investment portfolios that aim to generate outperformance and maximize their impact on the world. Cambridge Associates delivers a range of portfolio management services, including outsourced CIO, non-discretionary portfolio management, staff extension, and asset class mandates.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
4.5
3621136,211 ratings
Introducing S5:E2 Drug Affordability: The High Cost of Healing from Unseen Upside: Investments Beyond Their Returns.
Follow the show: Unseen Upside: Investments Beyond Their Returns
Prescription drug prices in the United States are 2.78 times higher than in other developed countries, but why?
We untangle the barriers surrounding drug affordability and find out why accessing life-saving medications is costly to so many. Joined by experts, advocates, and one Cystic Fibrosis patient relying on expensive medication to live, we examine the complex factors contributing to the high costs of drugs, from research and development to pricing strategies and supply chain dynamics. We also investigate potential solutions to improve access and affordability without compromising on drug innovation.
Guests include:
Unseen Upside: Investments Beyond Their Returns is developed in partnership with PRX, an award-winning podcast media company.
Cambridge Associates is a global investment firm that works with endowments, foundations, healthcare systems, pension plans, and private clients to implement and manage custom investment portfolios that aim to generate outperformance and maximize their impact on the world. Cambridge Associates delivers a range of portfolio management services, including outsourced CIO, non-discretionary portfolio management, staff extension, and asset class mandates.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
2,420 Listeners
4,165 Listeners
1,153 Listeners
6,486 Listeners
2,294 Listeners
8,691 Listeners
2,985 Listeners
2,328 Listeners
863 Listeners
3,611 Listeners
153,667 Listeners
14,321 Listeners
22 Listeners
8,556 Listeners
138 Listeners
2,141 Listeners
1,813 Listeners
3,448 Listeners
108 Listeners
831 Listeners
58 Listeners
1,078 Listeners
297 Listeners
198 Listeners
38,666 Listeners
88 Listeners
5 Listeners
161 Listeners
4,139 Listeners
111 Listeners
2,647 Listeners
102 Listeners
86 Listeners
27 Listeners